Background Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL) is
characterized by a gene-expression profile similar to that of BCR–ABL1–positive ALL, …

Despite great progress in curing childhood acute lymphoblastic leukemia (ALL), survival after
relapse remains poor. We analyzed survival after relapse among 9585 pediatric patients …

The Children's Cancer Group (CCG) and the Pediatric Oncology Group (POG) joined to
form the Children's Oncology Group (COG) in 2000. This merger allowed analysis of clinical, …

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using
whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we …

Recent genomic studies have identified chromosomal rearrangements defining new subtypes
of B-progenitor acute lymphoblastic leukemia (B-ALL), however many cases lack a known …

Importance Standard chemotherapy for first relapse of B-cell acute lymphoblastic leukemia (B-ALL)
in children, adolescents, and young adults is associated with high rates of severe …

Minimal residual disease (MRD) is highly prognostic in pediatric B-precursor acute lymphoblastic
leukemia (B-ALL). In Children’s Oncology Group high-risk B-ALL study AALL0232, we …

Purpose Survival for children and young adults with high-risk B-acute lymphoblastic
leukemia has improved significantly, but 20% to 25% of patients are not cured. Children's …

Relapsed childhood acute lymphoblastic leukemia (ALL) carries a poor prognosis, despite
intensive retreatment, owing to intrinsic drug resistance 1 , 2 . The biological pathways that …

Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk
subtype characterized by genomic alterations that activate cytokine receptor and kinase …